US EditionQ3 EPS Estimates for Krystal Biotech Cut by William Blair
Summary by ETF Daily News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Q3 EPS Estimates for Krystal Biotech Cut by William Blair
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Stock analysts at William Blair lowered their Q3 2025 EPS estimates for Krystal Biotech in a research report issued on Monday, August 4th. William Blair analyst S. Corwin now expects that the company will earn $1.14 per share for the quarter, down from their previous estimate of […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
